Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).
暂无分享,去创建一个
M. Qazilbash | D. Couriel | R. Champlin | S. Giralt | J. Gajewski | C. Ha | P. Kebriaei | I. Khouri | M. Lima | C. Ippoliti | R. Saliba | C. Ma